Pedal edema associated with atypical antipsychotics

被引:5
|
作者
Munshi, Santanu [1 ]
Mukherjee, Shatavisa [1 ]
Saha, Indranil [2 ]
Sen, Sukanta [1 ]
机构
[1] Med Coll & Hosp, Calcutta Sch Trop Med, Dept Clin & Expt Pharmacol, Kolkata, W Bengal, India
[2] Med Coll & Hosp, Dept Psychiat, Kolkata, W Bengal, India
关键词
Atypical antipsychotics; pedal edema; quetiapine; risperidone; QUETIAPINE;
D O I
10.4103/0253-7613.174571
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study describes a patient diagnosed as a case of bipolar affective disorder complaining of bothersome incidence of pedal edema 1 month after the initiation of atypical antipsychotic regimen with risperidone and quetiapine. All hematological and biochemical profiles were found to be normal. On discontinuation of risperidone, the condition remained unresolved even after 2 weeks, and the edema progressed reaching her calves. On tapering the dose of quetiapine, she started showing gradual improvement in edematous condition. Quetiapine was slowly discontinued. No further recurrence of edema occurred, and hence, no further medication changes were implemented. Pedal edema was found to be resolved within weeks of dechallenge of the regimen. Naranjo adverse drug reaction probability scale gave a score of 7 which denotes "probable" adverse drug reaction with quetiapine.
引用
收藏
页码:88 / 90
页数:3
相关论文
共 50 条
  • [41] Atypical antipsychotics associated with insulin resistance in New Zealand Maori
    Poa, N. R.
    Edgar, P. F.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2006, 40 : A124 - A125
  • [42] Report: Belgian consensus on metabolic problems associated with atypical antipsychotics
    de Nayer, AR
    de Hert, M
    Scheen, A
    Van Gaal, L
    Peuskens, J
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 574 - 574
  • [43] Role of atypical antipsychotics in the treatment of psychosis and agitation associated with dementia
    Madhusoodanan, S
    Brenner, R
    Cohen, CI
    [J]. CNS DRUGS, 1999, 12 (02) : 135 - 150
  • [44] Bodyweight gain associated with atypical antipsychotics - Epidemiology and therapeutic implications
    Russell, JM
    Mackell, JA
    [J]. CNS DRUGS, 2001, 15 (07) : 537 - 551
  • [45] Atypical antipsychotics reduce prepulse inhibition deficits associated with schizophrenia
    [J]. Nature Clinical Practice Neurology, 2006, 2 (12): : 643 - 644
  • [46] Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics
    Susana Barbosa Ribeiro
    Aurigena Antunes de Araújo
    Caroline Addison Xavier Medeiros
    Katarina Melo Chaves
    Maria do Socorro Costa Feitosa Alves
    Antonio Gouveia Oliveira
    Rand Randall Martins
    [J]. European Journal of Clinical Pharmacology, 2017, 73 : 351 - 355
  • [47] Treatment-emergent adverse events associated with atypical antipsychotics
    Cha, Danielle S.
    McIntyre, Roger S.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (11) : 1587 - 1598
  • [48] Role of Atypical Antipsychotics in the Treatment of Psychosis and Agitation Associated with Dementia
    Subramoniam Madhusoodanan
    Ronald Brenner
    Carl I. Cohen
    [J]. CNS Drugs, 1999, 12 : 135 - 150
  • [49] Atypical antipsychotics associated with insulin resistance in New Zealand Maori
    Poa, N. R.
    Edgar, P. F.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 505 - 505
  • [50] Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics
    Ribeiro, Susana Barbosa
    de Araujo, Aurigena Antunes
    Xavier Medeiros, Caroline Addison
    Chaves, Katarina Melo
    Costa Feitosa Alves, Maria do Socorro
    Oliveira, Antonio Gouveia
    Martins, Rand Randall
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (03) : 351 - 355